Press Enter to search · Esc to close
The world's most common chronic liver disease just got a new name. The bigger shift: doctors now treat it as a cardiometabolic problem, because most patients die of heart disease, not cirrhosis.
A Hong Kong cohort suggests the trendy 1-hour glucose test isn't always the smarter pick — especially if young-onset type 2 diabetes runs in your family.
New research links liver fibrosis to clogged arteries — and reframes a condition once filed under 'gastro' as a heart-and-metabolism story parents can't afford to ignore.
A new PRISMA-guided meta-analysis pools data from 179 cohorts to quantify the years diabetes can cost — and what that means for the metabolic choices we make in the meantime.
A new Thai cohort study sorts pre-diabetic adults into six clusters with sharply different risks for type 2 diabetes, vascular damage and death — a glimpse of metabolic care that finally treats people as individuals.
A 56-week randomized trial finally tests what patients and surgeons have been doing off-script: adding liraglutide when the scale starts climbing again after bypass.
The American Heart Association's updated 0–100 cardiovascular score now includes sleep — and new French cohort data show how few adults actually land in the 'high' zone.
A major Herz review reaffirms that Mediterranean eating, structured movement and smoking cessation move the endpoints that matter — a useful corrective in the GLP-1 era.
A massive Japanese cohort study tracked the exact moments adults quit — or started — drinking, and watched their LDL and HDL move in opposite directions.
Two 2025 papers connect how we eat — and when — to the metabolic stress pathways behind a stubborn form of heart failure. The science is promising, the certainty is not.